EFFECT OF INDOMETHACIN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FELODIPINE

被引:20
作者
HARDY, BG
BARTLE, WR
MYERS, M
BAILEY, DG
EDGAR, B
机构
[1] VICTORIA HOSP,DEPT PHARM SERV,LONDON N6A 4G5,ONTARIO,CANADA
[2] AB HASSLE,CARDIOVASC RES LABS,S-43183 MOLNDAL,SWEDEN
关键词
D O I
10.1111/j.1365-2125.1988.tb05295.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:557 / 562
页数:6
相关论文
共 17 条
  • [1] Ahnoff M, 1984, J Pharm Biomed Anal, V2, P519, DOI 10.1016/0731-7085(84)80055-2
  • [2] EFFECTS OF FELODIPINE ON RENAL-FUNCTION IN ANIMALS
    DIBONA, GF
    [J]. DRUGS, 1985, 29 : 168 - 175
  • [3] FELODIPINE KINETICS IN HEALTHY-MEN
    EDGAR, B
    REGARDH, CG
    JOHNSSON, G
    JOHANSSON, L
    LUNDBORG, P
    LOFBERG, I
    RONN, O
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 205 - 211
  • [4] EFFECT OF INHIBITORS OF PROSTAGLANDIN SYNTHESIS ON HEPATIC DRUG CLEARANCE
    FEELY, J
    WOOD, AJJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) : 109 - 111
  • [5] THE EFFECT OF 8 WEEKS TREATMENT WITH THE CALCIUM-ANTAGONIST FELODIPINE ON BLOOD-PRESSURE, HEART-RATE, WORKING CAPACITY, PLASMA-RENIN ACTIVITY, PLASMA ANGIOTENSIN-II, URINARY CATECHOLAMINES AND ALDOSTERONE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KATZMAN, PL
    HULTHEN, UL
    HOKFELT, B
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (06) : 633 - 640
  • [6] FELODIPINE IN HYPERTENSION
    MACE, PJE
    STALLARD, TJ
    LITTLER, WA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (04) : 383 - 389
  • [7] FELODIPINE COMPARED TO NIFEDIPINE AS 3RD-LINE DRUG IN RESISTANT HYPERTENSION
    MACLEAN, D
    MITCHELL, ET
    READMAN, AS
    [J]. ANGIOLOGY, 1986, 37 (11) : 840 - 845
  • [8] RONN O, 1985, DRUGS, V29, P16
  • [9] ESTIMATING DIMENSION OF A MODEL
    SCHWARZ, G
    [J]. ANNALS OF STATISTICS, 1978, 6 (02) : 461 - 464
  • [10] EFFECTS OF FELODIPINE ON HEMODYNAMICS AND EXERCISE CAPACITY IN PATIENTS WITH ANGINA-PECTORIS
    SHERIDAN, JV
    THOMAS, P
    ROUTLEDGE, PA
    SHERIDAN, DJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) : 391 - 396